Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01911819 · ClinicalTrials.gov registry record · NA
A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft
A NA study of Inadequate Bone Height in Maxillary Posterior Area, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT01911819: Completed NA study of Inadequate Bone Height in Maxillary Posterior Area, sponsored by Loma Linda University.
NCT01911819 is a NA study of Inadequate Bone Height in Maxillary Posterior Area that has completed, run by Loma Linda University. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01911819, a NA study of Inadequate Bone Height in Maxillary Posterior Area, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare new bone formation following bone graft in sinus using three different commercially available bone graft materials. The study hypothesis is that there is no difference in new bone formation among three bone graft materials under microscope.
Primary Outcome
Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.
Conditions Studied
Interventions
- PROCEDURE Sinus augmentation
- DRUG Equimatrix
- DRUG OSSIF-i sem
- DRUG Bio-oss
Study Locations (1)
California
- Loma Linda University School of Dentistry - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01911819 record still lists
NCT01911819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Inadequate Bone Height in Maxillary Posterior Area appearing as the primary indexed condition, and to 4 interventions - of which Sinus augmentation is the first listed.
NCT01911819 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01911819 about?
NCT01911819 is a clinical study titled "A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft". The purpose of this study is to compare new bone formation following bone graft in sinus using three different commercially available bone graft materials. The study hypothesis is that there is no difference in new bone formation among three bone graft materials under microscope.
What is the current status of trial NCT01911819?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-12. Estimated completion is 2016-06.
What conditions does trial NCT01911819 study?
This clinical trial studies the following conditions: Inadequate Bone Height in Maxillary Posterior Area.
What interventions are being tested in trial NCT01911819?
The interventions under investigation include: Sinus augmentation (PROCEDURE), Equimatrix (DRUG), OSSIF-i sem (DRUG), Bio-oss (DRUG).
Who is sponsoring clinical trial NCT01911819?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01911819 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01911819's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia